Web Results



Rofecoxib /ˌrɒfᵻˈkɒksɪb/ is a nonsteroidal anti-inflammatory drug (NSAID) that has now been withdrawn over safety concerns. It was marketed by Merck ...

Vioxx (rofecoxib) Questions and Answers - FDA


What action did Merck take today? Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib). 2. What is Vioxx? Vioxx is a COX-2 selective ...

Vioxx (Rofecoxib) Drug Information: Clinical Pharmacology ...


Learn about clinical pharmacology for the drug Vioxx (Rofecoxib).

Side Effects of Vioxx (Rofecoxib) Drug Center - RxList


Oct 20, 2015 ... Find a comprehensive guide to possible side effects when taking Vioxx ( Rofecoxib) for Professionals, Patients, and Caregivers.

Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib ...


Curr Med Res Opin. 2007 Aug;23(8):1859-66. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug ...

rofecoxib (Vioxx): Drug Facts, Side Effects and Dosing - MedicineNet


Sep 30, 2004 ... Get information on the arthritis drug rofecoxib (Vioxx) removed from the US market by the manufacturer.

Rofecoxib withdrawn - Medscape


Sep 30, 2004 ... Whitehouse Station, NJ - Merck has withdrawn its selective COX-2 inhibitor rofecoxib (Vioxx<sup>®</sup>) from all markets worldwide, following the ...

DrugBank: Rofecoxib


Rofecoxib is used for the treatment of osteoarthritis, rheumatoid arthritis, acute pain in adults, and primary dysmenorrhea, as well as acute treatment of migraine  ...

Cardiovascular Events Associated with Rofecoxib in a Colorectal ...


Original Article from The New England Journal of Medicine — Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention ...

Failing the Public Health — Rofecoxib, Merck, and the FDA — NEJM


On May 21, 1999, Merck was granted approval by the Food and Drug Administration (FDA) to market rofecoxib (Vioxx). On September 30, 2004, after more than ...

rofecoxib | Define rofecoxib at Dictionary.com
The world's most popular free online dictionary with definitions, spell check, word origins, example sentences, audio pronunciations, Word of the Day and more!
More Info

Rofecoxib (oral) medical facts from Drugs.com


Rofecoxib (Vioxx) was withdrawn from the U.S. market in 2004. Rofecoxib is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Rofecoxib ...

Vioxx (Rofecoxib) Drug Information: Description, User Reviews ...


Learn about the prescription medication Vioxx (Rofecoxib), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.

Lessons from the withdrawal of rofecoxib


Oct 16, 2004 ... Lessons from the withdrawal of rofecoxib. Patients would be safer if drug companies disclosed adverse events before licensing. Paul A Dieppe ...